Denali Therapeutics Inc.
Denali Therapeutics Inc.（DNLI）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
dnli · 股价预测 · 18 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 18 位华尔街分析师
Buy
18 位分析师
共识
评级分布
12 个月目标价
High
$40.00
Consensus
$30.80
+58.7% upside
Low
$23.00
Median: $31 · Last Close: $19.41
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$30.80
58.7% upside
High Target
$40
106.1%
Low Target
$23
18.5%
Current Price
$19.41
as of today
Based on analyst price targets, the DNLI stock price prediction for the next 12 months ranges from $23 to $40. The consensus DNLI price forecast of $30.80 implies 58.7% upside from the current price of $19.41.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $19.46 | ↑ 0.28% |
1-day model range: $19.35–$19.57. Peak: $19.57 (+0.28%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $14 | -28.9% |
| 2028 | $11 | -41.2% |
| 2029 | $10 | -47.4% |
| 2030 | $10 | -50.6% |
| 2031 | — | -52.5% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · DNLI · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-26 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-05-14 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-05-11 | BTIG | Maintains | Buy→Buy |
| 2026-05-08 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-22 | Leerink Partners | Maintains | Outperform→Outperform |
| 2026-04-07 | Baird | Maintains | Outperform→Outperform |
| 2026-03-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-26 | Goldman Sachs | Maintains | Buy→Buy |
| 2026-03-26 | Stifel | Maintains | Buy→Buy |
| 2026-03-26 | Morgan Stanley | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Denali Therapeutics Inc. (DNLI) stock. Of the recent 86 rating actions, 2 were upgrades and 3 were downgrades. 18 analysts currently cover DNLI.
分析师推荐趋势
DNLI analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 4 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$48M
↓ 88.6% YoY
Revenue Next Year
$113M
↑ 135.6% YoY
EPS This Year
$-2.46
EPS Next Year
$-2.43
↓ 1.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast DNLI EPS of $-2.46 for the current fiscal year, based on estimates from 14 analysts. The DNLI revenue forecast is $48M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
DNLI 股价预测由两类独立数据源支撑：来自 18 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。DNLI 的共识目标价为 $30.80（+58.7% 上行空间），分析师共识为 Buy。
DNLI 的短期预测（明日）为 $19.46（+0.28%）。 DNLI 对 2027 年的股价预测均值为 $14。 DNLI 对 2030 年的预测区间为 $9–$10。
Denali Therapeutics Inc. 在 NASDAQ 上市，代码 DNLI。DNLI 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
DNLI 预测 · 8 个问题根据 18 位华尔街分析师，DNLI 的 12 个月平均目标价为 $30.80，最高 $40.00、最低 $23.00。若有图表，中位目标价可在上方查看。相对当前价 $19.41，隐含约 +58.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.